Richter's Esmya drug may have contributed to liver damage cases: EMA

BUDAPEST (Reuters) - Hungarian drugmaker Richter's Esmya medicine used to treat benign tumors of the womb may have contributed to some cases of serious liver damage, European health regulators said on Friday after a months-long review.